HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Viacheslav O Nikolaev Selected Research

Chronic Obstructive Pulmonary Disease (COPD)

1/2020Cigarette smoke exposure alters phosphodiesterases in human structural lung cells.
1/2020A-Kinase Anchoring Proteins Diminish TGF-β1/Cigarette Smoke-Induced Epithelial-To-Mesenchymal Transition.
1/2019Phosphodiesterases as therapeutic targets for respiratory diseases.
1/2018Cigarette smoke up-regulates PDE3 and PDE4 to decrease cAMP in airway cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Viacheslav O Nikolaev Research Topics

Disease

19Heart Failure
12/2023 - 01/2007
6Cardiomegaly (Heart Hypertrophy)
01/2021 - 11/2011
6Hypertrophy
01/2020 - 01/2014
5Cardiac Arrhythmias (Arrythmia)
03/2024 - 03/2010
4Cardiomyopathies (Cardiomyopathy)
11/2023 - 07/2007
4Atrial Fibrillation
01/2023 - 07/2015
4Chronic Obstructive Pulmonary Disease (COPD)
01/2020 - 01/2018
4Inflammation (Inflammations)
01/2019 - 01/2016
3Neoplasms (Cancer)
11/2023 - 01/2017
3Dilated Cardiomyopathy (Cardiomyopathy, Congestive)
11/2023 - 07/2007
3Myocardial Infarction
11/2023 - 12/2017
3Hypoxia (Hypoxemia)
11/2021 - 01/2016
3Heart Diseases (Heart Disease)
01/2019 - 09/2014
3Fibrosis (Cirrhosis)
09/2015 - 01/2014
2Cardiovascular Diseases (Cardiovascular Disease)
01/2020 - 07/2017
2Muscular Dystrophies (Muscular Dystrophy)
01/2020 - 01/2017
2Lung Diseases (Lung Disease)
01/2020 - 01/2018
2Ischemia
12/2017 - 01/2016
2Takotsubo Cardiomyopathy
08/2017 - 08/2012
1Myocarditis (Carditis)
11/2023
1Coronary Artery Disease (Coronary Atherosclerosis)
11/2023
1Type 2 Diabetes Mellitus (MODY)
01/2023
1Insulin Resistance
01/2023
1Necrosis
01/2022
1Hypertension (High Blood Pressure)
01/2022
1Dysferlinopathy
01/2020
1Chronic Bronchitis
01/2020
1Lymphoma (Lymphomas)
01/2019
1Atherosclerosis
01/2019
1Bronchitis
01/2019
1Asthma (Bronchial Asthma)
01/2019
1Respiratory Tract Diseases (Respiratory Tract Disease)
01/2019
1Reperfusion Injury
12/2017
1Tachycardia (Tachyarrhythmias)
11/2017

Drug/Important Bio-Agent (IBA)

7Phosphoric Diester Hydrolases (Phosphodiesterases)IBA
01/2023 - 10/2012
6Adenosine Monophosphate (AMP)IBA
11/2023 - 07/2007
6Adrenergic Receptors (Adrenergic Receptor)IBA
01/2020 - 01/2015
5Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA
03/2024 - 10/2012
5Guanosine Monophosphate (5' Guanylic Acid)IBA
11/2021 - 04/2014
4CalciumIBA
01/2023 - 10/2011
4Proteins (Proteins, Gene)FDA Link
01/2023 - 01/2015
4Natriuretic PeptidesIBA
10/2022 - 04/2015
4Adrenergic Agents (Adrenergic Drugs)IBA
08/2017 - 10/2012
4Atrial Natriuretic Factor (ANF)IBA
01/2016 - 11/2011
3AntibodiesIBA
01/2020 - 07/2007
2ButyrophilinsIBA
11/2023 - 02/2023
2sacubitril and valsartan sodium hydrate drug combinationIBA
01/2022 - 10/2020
2Phosphodiesterase 4 InhibitorsIBA
01/2020 - 01/2019
2Protein Isoforms (Isoforms)IBA
01/2020 - 10/2012
2RoflumilastIBA
01/2020 - 01/2019
2Soluble Guanylyl CyclaseIBA
01/2020 - 12/2017
2DysferlinIBA
01/2020 - 01/2017
2SmokeIBA
01/2020 - 01/2018
2AutoantibodiesIBA
01/2020 - 07/2007
2diethylstilbestrol monophosphate (PDES)IBA
01/2019 - 01/2018
2Cyclic GMP-Dependent Protein Kinases (Protein Kinase G)IBA
12/2017 - 01/2014
2CatecholaminesIBA
08/2017 - 10/2012
2Cyclic NucleotidesIBA
07/2017 - 01/2017
2Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA
07/2015 - 07/2014
2beta Adrenergic ReceptorsIBA
10/2013 - 01/2007
1ITI-214IBA
12/2023
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
11/2023
1Cytidine Monophosphate (CMP)IBA
11/2023
1Messenger RNA (mRNA)IBA
11/2023
1beta-1 Adrenergic Receptors (beta 1 Adrenergic Receptor)IBA
11/2023
1AntigensIBA
02/2023
1Metformin (Glucophage)FDA LinkGeneric
01/2023
1Triglycerides (Triacylglycerol)IBA
01/2023
1MyokinesIBA
10/2022
1RNA (Ribonucleic Acid)IBA
10/2022
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
01/2022
1LipopolysaccharidesIBA
01/2022
1salicylhydroxamic acid (SHAM)IBA
01/2022
1LipidsIBA
01/2021
1Serotonin (5 Hydroxytryptamine)IBA
01/2021
1Angiotensin Receptors (Angiotensin II Receptor)IBA
10/2020
1Neprilysin (Neutral Endopeptidase)IBA
10/2020
1FenoterolIBA
01/2020
1Calmodulin (Calcium-Dependent Activator Protein)IBA
01/2020
1cilostamideIBA
01/2020
1Complex MixturesIBA
01/2020
1CalcineurinIBA
01/2020
1EpitopesIBA
01/2020
1Peptides (Polypeptides)IBA
01/2020
1RolipramIBA
01/2020
1polyprolineIBA
01/2020
1Phosphoric Monoester Hydrolases (Phosphatases)IBA
01/2020
1DisulfidesIBA
01/2020
1Histones (Histone)IBA
01/2019
1phospholemmanIBA
01/2019
1Adenosine Triphosphate (ATP)IBA
01/2019
1Sodium-Potassium-Exchanging ATPase (Sodium, Potassium ATPase)IBA
01/2019
1Adenosine Triphosphatases (ATPase)IBA
01/2019
1Adenine NucleotidesIBA
01/2019
1SodiumIBA
01/2019
1Calcium-Activated Potassium Channels (Calcium-Activated Potassium Channel)IBA
12/2017
1Large-Conductance Calcium-Activated Potassium Channels (Maxi-K Channels)IBA
12/2017
1Acetylcholine (Acetylcholine Chloride)FDA Link
11/2017
1Neurotransmitter Agents (Neurotransmitter)IBA
11/2017

Therapy/Procedure

5Therapeutics
12/2023 - 01/2015